Kyowa Kirin Co (TSE:4151) Cash-to-Debt : No Debt ⁽¹⁾ (As of Sep. 2023)

View and export this data going back to 1949. Start your Free Trial

What is Kyowa Kirin Co Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Kyowa Kirin Co's cash to debt ratio for the quarter that ended in Sep. 2023 was No Debt ⁽¹⁾.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Kyowa Kirin Co could pay off its debt using the cash in hand for the quarter that ended in Sep. 2023.

(1) Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

The historical rank and industry rank for Kyowa Kirin Co's Cash-to-Debt or its related term are showing as below:

TSE:4151' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.5 Med: No Debt Max: No Debt
Current: No Debt

During the past 13 years, Kyowa Kirin Co's highest Cash to Debt Ratio was No Debt. The lowest was 0.50. And the median was No Debt.

TSE:4151's Cash-to-Debt is ranked better than
99.71% of 1047 companies
in the Drug Manufacturers industry
Industry Median: 0.95 vs TSE:4151: No Debt

Kyowa Kirin Co Cash-to-Debt Historical Data

The historical data trend for Kyowa Kirin Co's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Kyowa Kirin Co Cash-to-Debt Chart

Kyowa Kirin Co Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Cash-to-Debt

Get a 7-Day Free Trial

No Debt

Kyowa Kirin Co Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Cash-to-Debt	Get a 7-Day Free Trial															No Debt	No Debt	No Debt	No Debt	No Debt

Competitive Comparison of Kyowa Kirin Co's Cash-to-Debt

For the Drug Manufacturers - General subindustry, Kyowa Kirin Co's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kyowa Kirin Co's Cash-to-Debt Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kyowa Kirin Co's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Kyowa Kirin Co's Cash-to-Debt falls into.

Kyowa Kirin Co Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Kyowa Kirin Co's Cash to Debt Ratio for the fiscal year that ended in Dec. 2022 is calculated as:

Kyowa Kirin Co had no debt ⁽¹⁾.

Kyowa Kirin Co's Cash to Debt Ratio for the quarter that ended in Sep. 2023 is calculated as:

Kyowa Kirin Co had no debt ⁽¹⁾.

Kyowa Kirin Co (TSE:4151) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Kyowa Kirin Co Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Kyowa Kirin Co's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Kyowa Kirin Co (TSE:4151) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kyowa Kirin Co Ltd (TSE:4151) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

KYKOY:USA KYKOF:USA

Address

1-9-2,Otemachi, Chiyoda-ku, Otemachi Financial City Grand Cube, Tokyo, JPN, 100-0004

Website

http://www.kyowa-kirin.com

Kyowa Kirin Co Ltd is a drug manufacturing company that focuses on biologic medicines. Its operations emphasize four categories: nephrology, oncology, immunology and allergy, and the central nervous system. The company has two reportable segments, Pharmaceuticals and Biochemicals. The pharmaceuticals business manufactures and sells ethical pharmaceuticals, diagnostic reagents, and other products. The biochemicals business manufactures and sells raw materials for pharmaceutical and industrial use, mainly amino acids, nucleic acids and related compounds, healthcare products, and others.

Kyowa Kirin Co (TSE:4151) Headlines

No Headlines

Kyowa Kirin Co (TSE:4151) Cash-to-Debt : No Debt (1) (As of Sep. 2023)